Kansai Plus Atrial Fibrillation Trial
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 2113 participants.
Also called NCT01477983
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 2,113 participants
- Registry
-
NCT01477983
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Japan
- Registry status
- Completed
Technical summary
Registry record NCT01477983. Randomized; no masking; primary purpose treatment. Start 2011-11 (registry gives no type); primary completion 2017-07 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Kansai Plus Atrial Fibrillation Trial
- Acronym
- KPAF
- Condition
- Atrial Fibrillation
- Intervention (Procedure)
- ATP guide additional ablation.
- Intervention (Drug)
- Antiarrhythmic drug (AAD)
- Intervention (Procedure)
- ATP guide additional ablation.
- Intervention (Drug)
- Control
- Intervention (Procedure)
- Control
- Intervention (Drug)
- Antiarrhythmic drug (AAD)
- Intervention (Procedure)
- Control
- Intervention (Drug)
- Control
- Lead sponsor
- Kyoto University, Graduate School of Medicine
Record details
- Record id
cardio:ct-nct01477983- Content hash
200fc1c0cdafdbd0b0401a6c60410df50ed503ee9e414da21aea9f7eb759806a